DE69320336D1 - Isolierung, Charakterisierung und Verwendung der menschlichen Beta-Einheit des Immunglobulin E-Hochaffinitätsrezeptors - Google Patents

Isolierung, Charakterisierung und Verwendung der menschlichen Beta-Einheit des Immunglobulin E-Hochaffinitätsrezeptors

Info

Publication number
DE69320336D1
DE69320336D1 DE69320336T DE69320336T DE69320336D1 DE 69320336 D1 DE69320336 D1 DE 69320336D1 DE 69320336 T DE69320336 T DE 69320336T DE 69320336 T DE69320336 T DE 69320336T DE 69320336 D1 DE69320336 D1 DE 69320336D1
Authority
DE
Germany
Prior art keywords
immunoglobulin
high affinity
characterization
isolation
affinity receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69320336T
Other languages
English (en)
Other versions
DE69320336T2 (de
Inventor
Jean Kinet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE69320336D1 publication Critical patent/DE69320336D1/de
Publication of DE69320336T2 publication Critical patent/DE69320336T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69320336T 1992-04-16 1993-04-16 Isolierung, Charakterisierung und Verwendung der menschlichen Beta-Einheit des Immunglobulin E-Hochaffinitätsrezeptors Expired - Fee Related DE69320336T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/869,933 US5770396A (en) 1992-04-16 1992-04-16 Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
PCT/US1993/003419 WO1993021317A1 (en) 1992-04-16 1993-04-16 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN β SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E

Publications (2)

Publication Number Publication Date
DE69320336D1 true DE69320336D1 (de) 1998-09-17
DE69320336T2 DE69320336T2 (de) 1999-04-08

Family

ID=25354480

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69320336T Expired - Fee Related DE69320336T2 (de) 1992-04-16 1993-04-16 Isolierung, Charakterisierung und Verwendung der menschlichen Beta-Einheit des Immunglobulin E-Hochaffinitätsrezeptors

Country Status (8)

Country Link
US (3) US5770396A (de)
EP (1) EP0636177B1 (de)
JP (1) JP3534406B2 (de)
AT (1) ATE169676T1 (de)
AU (1) AU676680B2 (de)
CA (1) CA2118329C (de)
DE (1) DE69320336T2 (de)
WO (1) WO1993021317A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770396A (en) 1992-04-16 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
US5858981A (en) 1993-09-30 1999-01-12 University Of Pennsylvania Method of inhibiting phagocytosis
IL111105A (en) * 1993-09-30 2009-05-04 Univ Pennsylvania Use of a molecule capable of inhibiting the expression of syk kinase to prepare a pharmaceutical composition for inhibiting phagocytosis
CA2184631A1 (en) * 1994-03-17 1995-09-21 John C. Cambier Product and process for regulating signal transduction pathways
GB9510718D0 (en) * 1995-05-26 1995-07-19 Sod Conseils Rech Applic Antisense oligonucleotides
US5708156A (en) * 1996-05-31 1998-01-13 Ilekis; John V. Epidermal growth factor receptor-like gene product and its uses
US5945294A (en) * 1996-11-26 1999-08-31 Heska Corporation Method to detect IgE
US5871930A (en) * 1997-08-21 1999-02-16 Incyte Pharmaceuticals, Inc. High affinity immunoglobulin E receptor-like protein
US6057127A (en) * 1998-01-29 2000-05-02 Heska Corporation Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof
US6299875B1 (en) * 1998-06-04 2001-10-09 Panacea Pharmaceuticals, Llc Methods to block IGE binding to cell surface receptors of mast cells
CA2364160C (en) * 1999-02-25 2014-05-20 National Jewish Medical And Research Center Product and method for treatment of conditions associated with receptor-desensitization
AU6755300A (en) * 1999-08-09 2001-03-05 Genaissance Pharmaceuticals, Inc. Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene
AU6904100A (en) * 1999-08-24 2001-03-19 Genaissance Pharmaceuticals, Inc. Drug target isogenes: polymorphisms in the immunoglobulin e receptor beta chain gene
AU7830500A (en) * 1999-09-21 2001-04-24 Beth Israel Deaconess Medical Center Modulation of ige receptor cell surface expression
AU2001234797A1 (en) * 2000-02-02 2001-08-14 Biogen, Inc. Novel high affinity immunoglobulin epsilon receptor beta-subunit-like protein and nucleic acids encoding same
US20030022250A1 (en) * 2001-05-29 2003-01-30 Dreskin Stephen C. Functional IgE test methods and compositions
WO2004108929A1 (ja) * 2003-06-04 2004-12-16 Nihon University School Juridical Person 高親和性IgE受容体β鎖発現調節
WO2007043287A1 (ja) * 2005-09-20 2007-04-19 Nihon University 高親和性IgE受容体γ鎖転写調節
IN2014DN10991A (de) * 2012-05-25 2015-09-25 Cellectis
KR102141259B1 (ko) * 2012-09-04 2020-08-05 셀렉티스 멀티―체인 키메라 항원 수용체 및 그것의 용도들

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
US4620948A (en) 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4477446A (en) * 1983-07-01 1984-10-16 Usv Pharmaceutical Corporation 1-Benzazepines and their pharmaceutical uses
US4946788A (en) * 1985-06-11 1990-08-07 Ciba-Geigy Corporation Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
EP0286700A1 (de) * 1987-04-11 1988-10-19 Kishimoto, Tadamitsu, Prof. Biologisch aktives rekombiniertes menschliches auflösbares FcR-Fragment, dieses FcR-Fragment kodierendes Plasmid sowie dessen Herstellung
US4940782A (en) * 1987-06-08 1990-07-10 G. D. Searle & Co. Monoclonal antibodies against IgE-associated determinants, hybrid cell lines producing these antibodies, and use therefore
US4962035A (en) * 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof
EP0321601A1 (de) * 1987-12-22 1989-06-28 Kishimoto, Tadamitsu, Prof. Auflösbarer rekombinierter Fc-Epsilon-Rezeptor, dessen Herstellung und Verwendung
US5091313A (en) * 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
CA2000878C (en) * 1988-10-18 1999-06-29 Jean-Pierre Kinet Cdnas coding for the subunit of the high-affinity receptor for immunoglobulin e
CA2059842A1 (en) * 1991-02-11 1992-08-12 Richard A. Chizzonite Ige-receptor-antibodies
ATE233813T1 (de) * 1991-08-14 2003-03-15 Genentech Inc Veränderte immunglobuline für spezifische fc- epsilon rezeptoren
US5770396A (en) 1992-04-16 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E

Also Published As

Publication number Publication date
JP3534406B2 (ja) 2004-06-07
US5807988A (en) 1998-09-15
AU4283493A (en) 1993-11-18
CA2118329A1 (en) 1993-10-28
DE69320336T2 (de) 1999-04-08
ATE169676T1 (de) 1998-08-15
EP0636177B1 (de) 1998-08-12
CA2118329C (en) 2005-11-29
JPH07506486A (ja) 1995-07-20
US5770396A (en) 1998-06-23
AU676680B2 (en) 1997-03-20
EP0636177A1 (de) 1995-02-01
WO1993021317A1 (en) 1993-10-28
US6171803B1 (en) 2001-01-09

Similar Documents

Publication Publication Date Title
DE69320336T2 (de) Isolierung, Charakterisierung und Verwendung der menschlichen Beta-Einheit des Immunglobulin E-Hochaffinitätsrezeptors
ATE182901T1 (de) Für androgen-rezeptor-protein kodierende dna
ATE45382T1 (de) Biosynthetisch hergestellter humannervenwachstumsfaktor, verfahren zu seiner herstellung, diesen faktor enthaltende zusammensetzungen, diesen faktor codierende dna- sequenz, vektoren, die diese sequenz enthalten und dadurch transformierte wirtszellen.
ATE66693T1 (de) Rekombinante dns-sequenzen, diese enthaltende vektoren und verfahren zur verwendung derselben.
HU9303515D0 (en) Pyrrolo-pyrimidines
ATE191503T1 (de) Somatostatinrezeptoren
DE68927697T2 (de) Fluor substituierte Benzocycloheptapyridine, Zusammensetzungen und Verfahren zur Verwendung derselben als antihistaminische Verbindungen
DE69735942D1 (de) Neuartige inhibitoren der aktivität des wachstumsfaktors für gefäss-endothelzellen (vegf), ihre verwendungen und verfahren zu ihrer herstellung
DE69824597D1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
ATE226216T1 (de) Netrinrezeptoren
DK0851926T3 (da) Varianter af humant rekombinant gamminterferon (rhu-IFN-gamma) med forøget termisk stabilitet
DK0845943T3 (da) Nye peptider afledt fra humant heat shock protein 60 til behandling af diabetes, sammensætninger, fremgangsmåder og kits
MXPA02008239A (es) Gen humano de la esquizofrenia.
DE3851925D1 (de) Alkylaminalkoxyphenyl-Derivate, Verfahren zur Verwendung und sie enthaltende Zusammensetzungen.
EP0290948A3 (de) Oncostatin M und neue Zusammensetzungen mit anti-neoplastischer Aktivität
SE9801148D0 (sv) New receptors
ATE145426T1 (de) Für die gamma-untereinheit des rezeptors mit hoher affinität für immunglobulin e kodierende cdnas
YU199691A (sh) Receptor za humani interleukin-5
AU669149B2 (en) Expression signal-peptide-free staphylokinases
DK57487A (da) Humant lymphotoxinpolypeptidderivat og fremgangsmaade til fremstilling deraf, dna-fragment, som koder for derivatet, rekombinante plasmider, som har inkorporeret fragmentet, og biologisk rene kulturer af mikroorganismer indeholdende saadanne plasmider
DE69322770D1 (de) Zyklische anti-tumorpromotor-verbindungen, zusammensetzungen und verfahren zur herstellung sowie ihre verwendung
DK0941341T3 (da) Nukleotidsekvens, der koder for en flavinmonooxygenase, det tilsvarende protein og deres anvendelser inden for diagnostik og terapi
DK0811068T3 (da) Humane DNase I varianter
ATE279521T1 (de) Regulierende nukleinsaeuresequenzen und verwendungen
Nakamura et al. CLONING OF THE MOUSE INTERLEUKIN 2 RECEPTOR y CHAIN: DEMONSTRATION OF FUNCTIONAL, DIFFERENCES BETWEEN THE MOUSE AND HUMAN RECEPTORS

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee